Skip to Content

WATSON 240 0.5 (Lorazepam 0.5 mg)

Pill with imprint WATSON 240 0.5 is White, Round and has been identified as Lorazepam 0.5 mg. It is supplied by Watson Laboratories, Inc..

Lorazepam is used in the treatment of anxiety; icu agitation; insomnia; light anesthesia; nausea/vomiting and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 240 0.5

Lorazepam 0.5 mg WATSON 240 0.5
Lorazepam 0.5 mg WATSON 240 0.5
Lorazepam 0.5 mg WATSON 240 0.5 Front
Lorazepam 0.5 mg WATSON 240 0.5 Back
Lorazepam 0.5 mg WATSON 240 0.5

Lorazepam

Imprint
WATSON 240 0.5
Strength
0.5 mg
Color
White
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Benzodiazepine anticonvulsants, Benzodiazepines, Miscellaneous antiemetics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
lactose, magnesium stearate, microcrystalline cellulose, polacrilin potassium

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-0240 Watson Pharmaceuticals, Inc.
63739-0499 McKesson Packaging Services
66267-0133 Nucare Pharmaceuticals Inc. (repackager)
43063-0057 PDRX Pharmaceuticals Inc. (repackager)
55289-0402 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "WATSON 240 0.5"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.